全文获取类型
收费全文 | 4792篇 |
免费 | 329篇 |
国内免费 | 20篇 |
专业分类
耳鼻咽喉 | 46篇 |
儿科学 | 128篇 |
妇产科学 | 134篇 |
基础医学 | 741篇 |
口腔科学 | 114篇 |
临床医学 | 285篇 |
内科学 | 1270篇 |
皮肤病学 | 162篇 |
神经病学 | 361篇 |
特种医学 | 119篇 |
外科学 | 685篇 |
综合类 | 22篇 |
预防医学 | 387篇 |
眼科学 | 71篇 |
药学 | 312篇 |
中国医学 | 7篇 |
肿瘤学 | 297篇 |
出版年
2023年 | 43篇 |
2022年 | 64篇 |
2021年 | 168篇 |
2020年 | 99篇 |
2019年 | 188篇 |
2018年 | 153篇 |
2017年 | 109篇 |
2016年 | 116篇 |
2015年 | 150篇 |
2014年 | 192篇 |
2013年 | 219篇 |
2012年 | 312篇 |
2011年 | 321篇 |
2010年 | 156篇 |
2009年 | 161篇 |
2008年 | 252篇 |
2007年 | 228篇 |
2006年 | 269篇 |
2005年 | 232篇 |
2004年 | 225篇 |
2003年 | 216篇 |
2002年 | 202篇 |
2001年 | 116篇 |
2000年 | 125篇 |
1999年 | 105篇 |
1998年 | 63篇 |
1997年 | 35篇 |
1996年 | 38篇 |
1995年 | 34篇 |
1994年 | 38篇 |
1993年 | 18篇 |
1992年 | 49篇 |
1991年 | 52篇 |
1990年 | 55篇 |
1989年 | 38篇 |
1988年 | 34篇 |
1987年 | 32篇 |
1986年 | 18篇 |
1985年 | 33篇 |
1984年 | 15篇 |
1983年 | 19篇 |
1980年 | 10篇 |
1979年 | 23篇 |
1975年 | 10篇 |
1974年 | 7篇 |
1973年 | 8篇 |
1972年 | 8篇 |
1969年 | 7篇 |
1968年 | 8篇 |
1966年 | 10篇 |
排序方式: 共有5141条查询结果,搜索用时 15 毫秒
11.
The authors studied the effects of 4-hydroxyandrostene-3,17-dione (4-OHA) on progesterone (P), 17 beta-estradiol (E2), and 20 alpha-hydroxy-4-pregnen-3-one synthesis and pregnenolone accumulation in cultured human midluteal cells. A dose-dependent inhibition with and without human chorionic gonadotropin (hCG) of E2 and P production was observed. The accumulation of pregnenolone was significantly enhanced three to fourfold by 4-OHA in this culture system, as compared with control value. In addition, a sevenfold increase on pregnenolone accumulation was observed in the presence of 4-OHA plus 10 IU of hCG as compared with control values and 2.2-fold as compared with the 4-OHA treatments. These in vitro findings indicate a direct effect of 4-OHA on luteal steroidogenesis. Nevertheless, the suppressive effect of 4-OHA on P and E2 production is located at different sites of the steroidogenic pathway. In addition, the results demonstrate that hCG in the presence of 4-OHA stimulated pregnenolone accumulation, suggesting that the inhibition of P synthesis is in some steps after the formation of pregnenolone. These data indicate that the actions of 4-OHA on P or E2 formation have different inhibitory mechanisms. 相似文献
12.
13.
Modification of low density lipoprotein by advanced glycation end products contributes to the dyslipidemia of diabetes and renal insufficiency. 总被引:23,自引:2,他引:21
下载免费PDF全文
![点击此处可从《Proceedings of the National Academy of Sciences of the United States of America》网站下载免费的PDF全文](/ch/ext_images/free.gif)
R Bucala Z Makita G Vega S Grundy T Koschinsky A Cerami H Vlassara 《Proceedings of the National Academy of Sciences of the United States of America》1994,91(20):9441-9445
Atherosclerosis develops rapidly in patients with diabetes or renal insufficiency. Plasma lipoprotein profiles are frequently abnormal in these conditions and reflect an elevation in the level of the apoprotein B (ApoB)-containing components very low density lipoprotein (VLDL) and low density lipoprotein (LDL). High levels of circulating advanced glycation end products (AGEs) also occur in diabetes and end-stage renal disease (ESRD). These products arise from glucose-derived Amadori products and include AGE-modified peptides (AGE-peptides) which result from the catabolism of AGE-modified tissue proteins. AGE-peptides have been shown to crosslink protein amino groups and to accumulate in plasma as a consequence of renal insufficiency. To address potential mechanisms for the dyslipidemia of diabetes and ESRD, we investigated the possibility that circulating AGEs react directly with plasma lipoproteins to prevent their recognition by tissue LDL receptors. AGE-specific ELISA showed a significantly increased level of AGE-modified LDL in the plasma of diabetic or ESRD patients compared with normal controls. AGE-LDL formed readily in vitro when native LDL was incubated with either synthetic AGE-peptides or AGE-peptides isolated directly from patient plasma. LDL which had been modified by AGE-peptides in vitro to the same level of modification as that present in the plasma of diabetics with renal insufficiency exhibited markedly impaired clearance kinetics when injected into transgenic mice expressing the human LDL receptor. These data indicate that AGE modification significantly impairs LDL-receptor-mediated clearance mechanisms and may contribute to elevated LDL levels in patients with diabetes or renal insufficiency. This hypothesis was further supported by the observation that the administration of the advanced glycation inhibitor aminoguanidine to diabetic patients decreased circulating LDL levels by 28%. 相似文献
14.
Neodymium: YAG laser treatment of persistent pupillary membrane 总被引:1,自引:0,他引:1
A 16-year-old girl had a cosmetically unappealing persistent iridopupillary membrane in the left eye. Her best corrected visual acuity was 20/60, but this improved to 20/40 with pupillary dilation. Neodymium: YAG laser membranectomy resulted in 20/20 vision. This is the first reported case of persistent pupillary membrane treated with the Neodymium: YAG laser. 相似文献
15.
V. van Casteren P. Leurquin A. Bartelds F. Gurtner V. Massari S. Maurice-Tison A.T. Vega R. Mak 《European journal of epidemiology》1993,9(2):169-175
This study describes a p. year international data collection on the demand pattern for HIV-antibody tests in general practice recorded by 6 sentinel networks in 5 European countries. The purpose of the recording was to evaluate the use of HIV-antibody testing by general practitioners and the demand for testing among the general population. Sentinel networks of general practitioners are a possible and available instrument for monitoring the perception of the HIV-test, and indirectly of the threat of the HIV-epidemic by the public and by the general practitioners (GPs). Differences were found between the countries in the frequency of testing, the person asking the test and the reason for testing. Possible explanatory factors, such as differences in the routine testing of specific groups, differences in the training and in the role of the GP, differences in the characteristics of prevention policy, are discussed. The European comparison also offers the opportunity to reflect on common medical practice in dealing with demands for HIV-tests. 相似文献
16.
17.
Malignant fibrous histiocytoma of the lung 总被引:1,自引:0,他引:1
18.
19.
Juan Francisco Sánchez Muñoz-Torrero Paloma Barquilla Raul Velasco Maria del Carmen Fernández Capitan Nazaret Pacheco Lucia Vicente Jose Luis Chicón Sara Trejo Jose Zamorano Alicia Lorenzo Hernandez 《European journal of clinical pharmacology》2010,66(12):1257-1264
Objectives
This study was designed to assess the prevalence of adverse drug reactions (ADRs) in the internal medicine wards of two teaching Hospitals, identify the most common ADRs, the principal medications involved, and determine the risk factors implicated in the occurrence of such ADRs. 相似文献20.
W. Vaudry R. Ettenger P. Jara G. Varela-Fascinetto M. R. Bouw J. Ives R. Walker 《American journal of transplantation》2009,9(3):636-643
Oral valganciclovir is effective prophylaxis for cytomegalovirus (CMV) disease in adults receiving solid organ transplantation (SOT). However, data in pediatrics are limited. This study evaluated the pharmacokinetics and safety of valganciclovir oral solution or tablets in 63 pediatric SOT recipients at risk of CMV disease, including 17 recipients ≤2 years old. Patients received up to 100 days' valganciclovir prophylaxis; dosage was calculated using the algorithm: dose (mg) = 7 × body surface area × creatinine clearance (Schwartz method; CrCLS). Ganciclovir pharmacokinetics were described using a population pharmacokinetic approach. Safety endpoints were measured up to week 26. Mean estimated ganciclovir exposures showed no clear relationship to either body size or renal function, indicating that the dosing algorithm adequately accounted for both these variables. Mean ganciclovir exposures, across age groups and organ recipient groups were: kidney 51.8 ± 11.9 μg * h/mL; liver 61.7 ± 29.5 μg * h/mL; heart 58.0 ± 21.8 μg * h/mL. Treatment was well tolerated, with a safety profile similar to that in adults. Seven serious treatment-related adverse events (AEs) occurred in five patients. Two patients had CMV viremia during treatment but none experienced CMV disease. In conclusion, a valganciclovir-dosing algorithm that adjusted for body surface area and renal function provides ganciclovir exposures similar to those established as safe and effective in adults 相似文献